Paper39061024
MARCH1 negatively regulates TBK1-mTOR signaling pathway by ubiquitinating TBK1.
Li X and 11 others. BMC Cancer, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. MARCH1 negatively regulates TBK1-mTOR signaling pathway by ubiquitinating TBK1. Papers, record 39061024. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39061024
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Protein Serine-Threonine Kinases | Major topic |
| Signal Transduction | Major topic |
| TOR Serine-Threonine Kinases | Major topic |
| Ubiquitination | Major topic |
| Ubiquitin-Protein Ligases | Major topic |
| Cell Proliferation | Major topic |
| Humans | |
| Cell Line, Tumor | |
| Membrane Proteins | |
| Female | |
| Breast Neoplasms | |
| Cell Movement | |
| STING Protein |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| ZR2023QH126 | Natural Science Foundation of Shandong Province | PubMed | ||
| ZR2023QC303 | Natural Science Foundation of Shandong Province | PubMed | ||
| 50012304623 | Binzhou Medical University | PubMed | ||
| 50012304496 | Binzhou Medical University | PubMed |
Source PubMed
References73
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25959818 | Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. | Cell Rep | 2015 | https://conductscience.org/library/papers/25959818 | PubMed |
| 2 | 15467718 | Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. | Nat Cell Biol | 2004 | https://conductscience.org/library/papers/15467718 | PubMed |
| 3 | 29570996 | SnapShot: CGAS-STING Signaling. | Cell | 2018 | https://conductscience.org/library/papers/29570996 | PubMed |
| 4 | 25517615 | STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. | Immunity | 2014 | https://conductscience.org/library/papers/25517615 | PubMed |
| 5 | 21849678 | Ubiquitination of CD86 is a key mechanism in regulating antigen presentation by dendritic cells. | J Immunol | 2011 | https://conductscience.org/library/papers/21849678 | PubMed |
| 6 | 21138416 | Novel cross-talk within the IKK family controls innate immunity. | Biochem J | 2011 | https://conductscience.org/library/papers/21138416 | PubMed |
| 7 | 15718470 | Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. | Science | 2005 | https://conductscience.org/library/papers/15718470 | PubMed |
| 8 | 32926474 | EGFR-mediated tyrosine phosphorylation of STING determines its trafficking route and cellular innate immunity functions. | EMBO J | 2020 | https://conductscience.org/library/papers/32926474 | PubMed |
| 9 | 21464307 | IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21464307 | PubMed |
| 10 | 36988258 | TBK1 promotes thyroid cancer progress by activating the PI3K/Akt/mTOR signaling pathway. | Immun Inflamm Dis | 2023 | https://conductscience.org/library/papers/36988258 | PubMed |
| 11 | 31404274 | The Membrane-Associated MARCH E3 Ligase Family: Emerging Roles in Immune Regulation. | Front Immunol | 2019 | https://conductscience.org/library/papers/31404274 | PubMed |
| 12 | 31991682 | SV40 Large T Antigen Is Not Responsible for the Loss of STING in 293T Cells but Can Inhibit cGAS-STING Interferon Induction. | Viruses | 2020 | https://conductscience.org/library/papers/31991682 | PubMed |
| 13 | 36018392 | DNA damage induces STING mediated IL-6-STAT3 survival pathway in triple-negative breast cancer cells and decreased survival of breast cancer patients. | Apoptosis | 2022 | https://conductscience.org/library/papers/36018392 | PubMed |
| 14 | 16962653 | SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. | Cell | 2006 | https://conductscience.org/library/papers/16962653 | PubMed |
| 15 | 23524951 | mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6. | Nat Cell Biol | 2013 | https://conductscience.org/library/papers/23524951 | PubMed |
| 16 | 28356390 | The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity. | J Exp Med | 2017 | https://conductscience.org/library/papers/28356390 | PubMed |
| 17 | 36313698 | MARCH1 as a novel immune-related prognostic biomarker that shapes an inflamed tumor microenvironment in lung adenocarcinoma. | Front Oncol | 2022 | https://conductscience.org/library/papers/36313698 | PubMed |
| 18 | 31819015 | ciRs-6 upregulates March1 to suppress bladder cancer growth by sponging miR-653. | Aging (Albany NY) | 2019 | https://conductscience.org/library/papers/31819015 | PubMed |
| 19 | 26951929 | Agonist-Mediated Activation of STING Induces Apoptosis in Malignant B Cells. | Cancer Res | 2016 | https://conductscience.org/library/papers/26951929 | PubMed |
| 20 | 37395713 | TBK1 Knockdown Alleviates Axonal Transport Deficits in Retinal Ganglion Cells Via mTORC1 Activation in a Retinal Damage Mouse Model. | Invest Ophthalmol Vis Sci | 2023 | https://conductscience.org/library/papers/37395713 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42286644 | From energy metabolic homeostasis to immune remodeling: the role and therapeutic potential of STING signaling in the tumor microenvironment. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42286644 | PubMed |
| 42117108 | Integrative Transcriptomics Identifies Ubiquitination-Related Genes BIRC2, COPS5, and TBK1 as Novel Biomarkers of T-Cell Dysregulation in Amyotrophic Lateral Sclerosis. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42117108 | PubMed |
| 41046303 | Elucidating the risk factors and oncogene drivers of acute myeloid leukemia. | Hum Cell | 2025 | https://conductscience.org/library/papers/41046303 | PubMed |
| 40835619 | A genome-wide study on gene-nutrient interactions for hyperuricemia in a large Korean cohort (KoGES). | Sci Rep | 2025 | https://conductscience.org/library/papers/40835619 | PubMed |
| 40533483 | MARCH1, transcriptionally regulated by POU2F2, facilitates acute myeloid leukemia progression via inducing MYCT1 degradation. | Oncogene | 2025 | https://conductscience.org/library/papers/40533483 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MTOR | 2475 | PubTator's text mining | https://conductscience.org/library/genes/2475 | NCBI Gene |
| STING1 | 340061 | PubTator's text mining | https://conductscience.org/library/genes/340061 | NCBI Gene |
| TBK1 | 29110 | PubTator's text mining | https://conductscience.org/library/genes/29110 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39061024
GET https://conductscience.org/api/papers/v1/39061024/references?page=2